Form 4 for IDXX Idexx Laboratories
Accepted 2024-11-29 00:00:00 ET · period of report 2024-11-27 · accession 0000874716-24-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-29 | 2024-11-27 | IDXX | Vandebroek Sophie V. | Dir | S - Sale | $420.44 | -344 | 905 | -28% | -$144.6K | |
| 2024-11-29 | 2024-11-27 | IDXX | Vandebroek Sophie V. | Dir | G - Gift | $0.00 | -224 | 1,249 | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | S | D | 344 | $420.44 | 905 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-27 | G | D | 224 | $0.00 | 1,249 | D | — | — |